Authors:
Gensana, M
Altisent, C
Aznar, JA
Casana, P
Hernandez, F
Jorquera, JI
Magallon, M
Massot, M
Puig, L
Citation: M. Gensana et al., Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII, HAEMOPHILIA, 7(4), 2001, pp. 369-374
Authors:
Vidal, F
Farssac, E
Altisent, C
Puig, L
Gallardo, D
Citation: F. Vidal et al., Rapid hemophilia a molecular diagnosis by a simple DNA sequencing procedure: Identification of 14 novel mutations (vol 85, pg 580, 2001), THROMB HAEM, 86(2), 2001, pp. 727-727
Authors:
Vidal, F
Farssac, E
Altisent, C
Puig, L
Gallardo, D
Citation: F. Vidal et al., Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: Identification of 14 novel mutations, THROMB HAEM, 85(4), 2001, pp. 580-583
Authors:
Sauleda, S
Juarez, A
Esteban, JI
Altisent, C
Ruiz, I
Puig, L
Esteban, R
Guardia, J
Citation: S. Sauleda et al., Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders, HEPATOLOGY, 34(5), 2001, pp. 1035-1040
Authors:
Galan, AM
Tonda, R
Altisent, C
Maragall, S
Ordinas, A
Escolar, G
Citation: Am. Galan et al., Recombinant factor VIIa (NovoSeven (R)) restores deficient coagulation: Experience from an ex vivo model, SEM HEMATOL, 38(4), 2001, pp. 10-14
Authors:
Lorenzo, JI
Lopez, A
Altisent, C
Aznar, JA
Citation: Ji. Lorenzo et al., Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age, BR J HAEM, 113(3), 2001, pp. 600-603
Authors:
Sauleda, S
Esteban, JI
Altisent, C
Puig, L
Esteban, R
Guardia, J
Citation: S. Sauleda et al., Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C, THROMB HAEM, 83(6), 2000, pp. 807-810
Authors:
Briones, C
Mas, A
Gomez-Mariano, G
Altisent, C
Menedez-Arias, L
Soriano, V
Domingo, E
Citation: C. Briones et al., Dynamics of dominance of a dipeptide insertion in reverse transcriptase ofHIV-1 from patients subjected to prolonged therapy, VIRUS RES, 66(1), 2000, pp. 13-26
Authors:
Babiker, A
Darby, S
De Angelis, D
Kwart, D
Porter, K
Beral, V
Darbyshire, J
Day, N
Gill, N
Coutinho, R
Prins, M
van Benthem, B
Coutinho, R
Dabis, F
Marimoutou, C
Ruiz, I
Tusell, J
Altisent, C
Evatt, B
Jaffe, H
Kirk, O
Pedersen, C
Rosenberg, P
Goedert, J
Biggar, R
Melbye, M
Brettie, R
Downs, A
Hamouda, O
Touloumi, G
Karafoulidou, A
Katsarou, O
Donfield, S
Gomperts, E
Hilgartner, M
Hoots, K
Schoenbaum, E
Beral, V
Zangerle, R
Del Amo, J
Pezzotti, P
Rezza, G
Hutchinson, S
Day, N
De Angelis, D
Gore, S
Kingsley, L
Schrager, L
Rosenberg, P
Goedert, J
Melnick, S
Koblin, B
Eskild, A
Bruun, J
Sannes, M
Evans, B
Lepri, AC
Sabin, C
Buchbinder, S
Vittinghoff, E
Moss, A
Osmond, D
Winkelstein, W
Goldberg, D
Boufassa, F
Meyer, L
Egger, M
Francioli, P
Rickenbach, M
Cooper, D
Tindall, B
Sharkey, T
Vizzard, J
Kaldor, J
Cunningham, P
Vanhems, P
Vizzard, J
Kaldor, J
Learmont, J
Farewell, V
Berglund, O
Mosley, J
Operskalski, E
van den Berg, M
Metzger, D
Tobin, D
Woody, G
Rusnak, J
Hendrix, C
Garner, R
Hawkes, C
Renzullo, P
Garland, F
Darby, S
Ewart, D
Giangrande, P
Lee, C
Phillips, A
Spooner, R
Wilde, J
Winter, M
Babiker, A
Darbyshire, J
Evans, B
Gill, N
Johnson, A
Phillips, A
Porter, K
Lorenzo, JI
Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Authors:
Barretina, J
Blanco, J
Gutierrez, A
Puig, L
Altisent, C
Espanol, T
Caragol, I
Clotet, B
Este, JA
Citation: J. Barretina et al., Evaluation of the putative role of C-C chemokines as protective factors ofHIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives, TRANSFUSION, 40(4), 2000, pp. 461-467
Authors:
Vidal, F
Farssac, E
Altisent, C
Puig, L
Gallardo, D
Citation: F. Vidal et al., Factor IX gene sequencing by a simple and sensitive 15-hour procedure for haemophilia B diagnosis: identification of two novel mutations, BR J HAEM, 111(2), 2000, pp. 549-551
Authors:
Vidal, F
Farssac, E
Altisent, C
Puig, L
Gallardo, D
Citation: F. Vidal et al., A novel mutation (2409delT) in exon 14 of the factor VIII gene causes severe haemophilia A, HUMAN HERED, 50(4), 2000, pp. 266-267
Authors:
Montoro, JB
Altisent, C
Pico, M
Cabanas, MJ
Vila, M
Puig, LL
Citation: Jb. Montoro et al., Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor (vol 4, pg 762, 1998), HAEMOPHILIA, 5(5), 1999, pp. 371-371
Authors:
Tassies, D
Magallon, M
Quintana, M
Fernandez-Urgelles, M
Rodriguez-Pinto, C
Tusell, J
Altisent, C
Reverter, JC
Mazzara, R
Ordinas, A
Monteagudo, J
Citation: D. Tassies et al., Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs, HAEMATOLOG, 84(10), 1999, pp. 930-936
Authors:
Vallejo, A
Mas, A
Heredia, A
Altisent, C
Lorenzo, I
Soriano, V
Hewlett, IK
Citation: A. Vallejo et al., V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohortwith long-term non-progressive infection, AIDS, 13(4), 1999, pp. 532-534